Bex, A;
Grunwald, V;
Russo, P;
Tomita, Y;
Berghorn, E;
McHenry, MB;
Motzer, R;
(2018)
A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Nivolumab Plus Ipilimumab in Patients (pts) With Localized Renal Cell Carcinoma (RCC)who Are at High Risk of Relapse After Radical or Partial Nephrectomy (CheckMate 914).
Presented at: ESMO, Munich, Germany.
Preview |
Text
Bex CM914.pdf - Accepted Version Download (381kB) | Preview |
| Type: | Conference item (Presentation) |
|---|---|
| Title: | A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Nivolumab Plus Ipilimumab in Patients (pts) With Localized Renal Cell Carcinoma (RCC)who Are at High Risk of Relapse After Radical or Partial Nephrectomy (CheckMate 914) |
| Event: | ESMO |
| Location: | Munich, Germany |
| Dates: | 19 Oct - 23 Oct 2018 |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1093/annonc/mdy283 |
| Publisher version: | https://doi.org/10.1093/annonc/mdy283 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci > Department of Surgical Biotechnology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10080374 |
Archive Staff Only
 |
View Item |
